UPI MDR Deferral Report Sends Paytm, MobiKwik and Pine Labs Shares Down Up to 10%: What the Proposal to Push the 0.4% Merchant Fee to 1 January Means, the Exemption Plan, Who Gains and Loses and What to Watch
- October 8, 2026
- Posted by: Chaitanya Auti
- Category: News
8 Oct: report says UPI MDR may be deferred from 15 Oct to 1 Jan. Paytm -10% (lower circuit Rs 1,558.80), MobiKwik -8%, Pine Labs -4%. 0.4% fee on P2M above Rs 2,000.
Quick Answer
UPI MDR deferral is behind the sharp fall in payments stocks on 8 October, when Paytm dropped 10% to the lower circuit at Rs 1,558.80, wiping about Rs 10,972 crore from its market value, MobiKwik fell more than 8% to Rs 234.52 and Pine Labs more than 4% to Rs 170.21, after Business Standard reported that a proposal to defer the merchant discount rate to 1 January 2027 from 15 October is under consideration. The planned fee is 0.4% on UPI payments to merchants above Rs 2,000, capped at Rs 300, with consumers and person-to-person transfers staying free, and the deferral would give merchants relief through the festive season while the committee also considers exempting businesses with annual turnover of up to Rs 40 lakh. Payments stocks had rallied when the fee was announced on 15 September, because it creates a new revenue stream, so a delay of about 11 weeks and a wider exemption cut the near-term upside even though no final decision has been made. The losses eased by mid-morning, with Paytm down about 5%, MobiKwik about 7% and Pine Labs about 3%, and a decision is expected in the next few days.
UPI MDR deferral matters because the fee ended almost six years of free UPI merchant payments and was seen as a lifeline for payments companies whose core UPI business earns little. Retail associations had planned a ‘No UPI Day’ on 2 October before withdrawing it, and their pressure is cited in the report.
If you hold Paytm, MobiKwik or Pine Labs, this article covers what the UPI MDR deferral proposal says about the Rs 2,000 threshold, the Rs 300 cap and the 15 October date, how the Paytm share price hit Rs 1,558.80 and lost Rs 10,972 crore, the Rs 40 lakh exemption plan from the NPCI committee, the festive season relief, the impact on each company, scenarios and the risks.
Click Here – Get Free Investment Predictions
UPI MDR Deferral: What the Report and the Rules Say
| Item | Detail |
|---|---|
| Original start date | 15 October 2026, set by the NPCI framework announced on 15 September |
| Fee | 0.4% merchant discount rate on person-to-merchant UPI payments above Rs 2,000 |
| Cap | Rs 300, applying to payments of Rs 75,000 and above |
| Free categories | Consumer payments, person-to-person transfers and small payments |
| Proposal under consideration | UPI MDR deferral to 1 January 2027, after the festive season |
| Exemption plan | Businesses with annual turnover of up to Rs 40 lakh may be exempt, against the earlier monthly limit of Rs 1 lakh |
| Status | No final decision; expected in the next few days; NPCI had not responded to queries |
NPCI has said that payments above Rs 2,000 make up most of the volume of UPI merchant transactions, so the exemption plan matters as much as the UPI MDR deferral date for the size of the fee pool.
Check the Univest Screener for live data on fintech stocks
How the Paytm Share Price and Peers Reacted to the UPI MDR Deferral Report
| Stock | Early move on 8 October | Detail |
|---|---|---|
| Paytm (One97) | Down 10% at the open; about 5% lower by 10:22 am | Hit the lower circuit at Rs 1,558.80; market value fell below Rs 1 lakh crore |
| MobiKwik | Down more than 8% at the open; about 6.7% lower by 10:22 am | Fell to Rs 234.52 |
| Pine Labs | Down more than 4% at the open; about 2.7% lower by 10:22 am | Fell to Rs 170.21 |
The partial recovery shows that investors are waiting for the decision, and the UPI MDR deferral could reverse in either direction if the final order differs from the report.
Download the Univest iOS App or Univest Android App to track Paytm, MobiKwik and Pine Labs live.
Why the UPI MDR Deferral Matters for Payments Companies
- The fee creates revenue where UPI was free: Paytm said it would generate additional revenue from payments that were earlier free.
- Brokerages upgraded Paytm and Pine Labs after the announcement, betting on a new income stream.
- A UPI MDR deferral pushes the start of that revenue back by about 11 weeks, from 15 October to 1 January.
- A wider exemption for small merchants shrinks the pool of payments that carry the fee.
- The share that payment companies keep after sharing with banks and acquirers is not yet clear, so the earnings effect is uncertain.
For scale, a 0.4% fee on Rs 1 lakh crore of eligible volume is Rs 400 crore, my arithmetic, but the share that reaches each company depends on revenue sharing, so the UPI MDR deferral is a timing and size question and not a cancellation.
Impact of the UPI MDR Deferral on Paytm, Pine Labs and MobiKwik
| Company | Why the fee matters | Impact of a delay |
|---|---|---|
| Paytm | Large merchant network with payment devices and QR codes; fee turns free UPI volume into revenue | Largest fall, because the stock rallied most on the fee |
| Pine Labs | Most of its transactions already run on UPI, largely unmonetised; the fee adds an acquiring leg | Moderate fall; the fee thesis is delayed |
| MobiKwik | A small share of UPI, so the benefit is modest | Sharp fall because the stock is volatile |
These are my readings of the business models and not company guidance, and the effect of any UPI MDR deferral will show in Q3 and Q4 results.
Scenarios After the UPI MDR Deferral Report
| Scenario | What happens | Likely effect on the stocks |
|---|---|---|
| Deferral to 1 January confirmed | Fee starts after the festive season | A delay already priced in; stocks may stabilise |
| Fee starts on 15 October with wider exemptions | Smaller eligible pool | Partial recovery, but lower estimates |
| Fee shelved or reworked | No near-term revenue | Further fall, as in earlier reversals on MDR rumours |
In June 2025, Paytm fell 10% when the Finance Ministry called reports of a UPI fee ‘completely false’, which shows how sharply these stocks react to headlines on the UPI MDR.
Risks Behind the UPI MDR Deferral Trade
No final decision: The UPI MDR deferral is a report and not an order.
Merchant resistance: Retail associations are lobbying against the fee, and the UPI MDR deferral may be followed by dilution.
Revenue sharing: Banks and acquirers may keep most of the fee, whatever the UPI MDR deferral outcome.
Headline volatility: Payments stocks can swing 5% to 10% in a day on UPI news.
Market backdrop: A weak market and a rate hike add pressure.
What to Watch Next After the UPI MDR Deferral Report
- The decision of the UPI Steering Committee and any NPCI circular.
- Whether the Rs 40 lakh annual turnover exemption is adopted.
- Company commentary on revenue sharing and expected fee income.
- The reaction in Paytm, MobiKwik and Pine Labs after the decision.
- The 15 October date, which still stands until a change is announced.
Conclusion
The UPI MDR deferral report sent Paytm down 10%, MobiKwik more than 8% and Pine Labs more than 4%, because a push of the 0.4% merchant fee to 1 January and a wider exemption would delay and shrink a new revenue stream. No decision is final, so the next few days matter. Consult a SEBI-registered advisor before making any decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Paytm, MobiKwik and Pine Labs shares fall?
Ans. A report of a UPI MDR deferral to 1 January from 15 October would delay the new fee revenue.
What is the UPI MDR?
Ans. A 0.4% merchant discount rate on UPI person-to-merchant payments above Rs 2,000, capped at Rs 300, with consumers staying free.
Is the UPI MDR deferral confirmed?
Ans. No. A proposal is under consideration and a decision is expected in the next few days.
How much did the Paytm share price and peers fall?
Ans. On the UPI MDR deferral report, Paytm fell 10% to the lower circuit, MobiKwik more than 8% and Pine Labs more than 4% at the open.
What exemption is proposed?
Ans. Businesses with annual turnover of up to Rs 40 lakh may be exempt, against the earlier monthly limit of Rs 1 lakh.
Who benefits from the UPI MDR?
Ans. Payments companies, banks and acquirers, with the split not yet clear.
Will UPI stay free for consumers?
Ans. Yes. NPCI has said consumers pay nothing; the fee is on merchants.
Should I buy payments stocks after the fall?
Ans. This article does not constitute investment advice. The UPI MDR deferral is not final. Consult a SEBI-registered financial advisor.